{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:01:45Z","timestamp":1777179705393,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1124\/jpet.119.256354","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T19:35:19Z","timestamp":1555011319000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Impact of Pharmacological Manipulation of the \u03ba-Opioid Receptor System on Self-grooming and Anhedonic-like Behaviors in Male Mice"],"prefix":"10.1016","volume":"370","author":[{"given":"Eduardo R.","family":"Butelman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan D.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Prisinzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Jeanne","family":"Kreek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.256354_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1037\/1064-1297.12.3.163","article-title":"Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys","volume":"12","author":"Beardsley","year":"2004","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1124\/jpet.119.256354_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.256354_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00227239","article-title":"Cortex, striatum and cerebellum: control of serial order in a grooming sequence","volume":"90","author":"Berridge","year":"1992","journal-title":"Exp Brain Res"},{"key":"10.1124\/jpet.119.256354_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02245071","article-title":"Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay","volume":"115","author":"Broadbear","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.256354_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2012.05.005","article-title":"\u03ba-Opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction","volume":"35","author":"Butelman","year":"2012","journal-title":"Trends Neurosci"},{"key":"10.1124\/jpet.119.256354_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.256354_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/npp.2009.183","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats","volume":"35","author":"Carr","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.256354_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2009.06.018","article-title":"Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse","volume":"616","author":"Castagn\u00e9","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.256354_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fphar.2019.00088","article-title":"Repeated administration of norbinaltorphimine produces cumulative kappa opioid receptor inactivation","volume":"10","author":"Chavkin","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.119.256354_bib10","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41386-018-0015-y","article-title":"Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders","volume":"43","author":"Domi","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.256354_bib11","first-page":"30","article-title":"Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo","volume":"316","author":"Endoh","year":"1992","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1124\/jpet.119.256354_bib12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00008877-200512000-00005","article-title":"Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse","volume":"16","author":"Fantegrossi","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.119.256354_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/jpet.111.185108","article-title":"Pharmacological characterization of 2-methyl-N-((2\u2032-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for \u03ba-opioid receptors","volume":"339","author":"Grimwood","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.256354_bib14","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuroimage.2008.03.003","article-title":"Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans","volume":"41","author":"Hooker","year":"2008","journal-title":"Neuroimage"},{"key":"10.1124\/jpet.119.256354_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2016.03.061","article-title":"Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test","volume":"781","author":"Huang","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.256354_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neulet.2016.01.017","article-title":"Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests","volume":"615","author":"Huang","year":"2016","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.119.256354_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrn.2015.8","article-title":"Neurobiology of rodent self-grooming and its value for translational neuroscience","volume":"17","author":"Kalueff","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.119.256354_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fnbeh.2014.00340","article-title":"Dysregulation of the hypothalamus-pituitary-adrenal axis predicts some aspects of the behavioral response to chronic fluoxetine: association with hippocampal cell proliferation","volume":"8","author":"Khemissi","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1124\/jpet.119.256354_bib19","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2967\/jnumed.112.118877","article-title":"Determination of the in vivo selectivity of a new \u03ba-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey","volume":"54","author":"Kim","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1124\/jpet.119.256354_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0006-8993(03)02938-X","article-title":"Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys","volume":"982","author":"Ko","year":"2003","journal-title":"Brain Res"},{"key":"10.1124\/jpet.119.256354_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/npp.2013.236","article-title":"Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous \u03ba-opioids","volume":"39","author":"Leitl","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.256354_bib22","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/jcph.286","article-title":"Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects","volume":"54","author":"Lowe","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.119.256354_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.npp.1300860","article-title":"Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning","volume":"31","author":"McLaughlin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.256354_bib24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/mol.111.074195","article-title":"Duration of action of a broad range of selective \u03ba-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation","volume":"80","author":"Melief","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.256354_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1021\/np0205699","article-title":"Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A","volume":"66","author":"Munro","year":"2003","journal-title":"J Nat Prod"},{"key":"10.1124\/jpet.119.256354_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/jpet.115.229278","article-title":"Receptor occupancy of the \u03ba-opioid antagonist LY2456302 measured with positron emission tomography and the novel radiotracer 11C-LY2795050","volume":"356","author":"Naganawa","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.256354_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2967\/jnumed.114.147975","article-title":"Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the \u03ba opioid receptor","volume":"56","author":"Naganawa","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1124\/jpet.119.256354_bib28","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/jcbfm.2014.150","article-title":"Kinetic modeling of 11C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans","volume":"34","author":"Naganawa","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/jpet.119.256354_bib29","first-page":"007","article-title":"Kappa opioid receptor-mediated disruption of novel object recognition: relevance for psychostimulant treatment","volume":"S4","author":"Paris","year":"2011","journal-title":"J Addict Res Ther"},{"key":"10.1124\/jpet.119.256354_bib30","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.094276","article-title":"Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats","volume":"316","author":"Peckham","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.256354_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2011.04.017","article-title":"Identification of short-acting \u03ba-opioid receptor antagonists with anxiolytic-like activity","volume":"661","author":"Peters","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.256354_bib32","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jamapsychiatry.2014.1221","article-title":"Association of in vivo \u03ba-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology","volume":"71","author":"Pietrzak","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1124\/jpet.119.256354_bib33","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1021\/acschemneuro.8b00293","article-title":"Discrepancies in kappa opioid agonist binding revealed through PET imaging","volume":"10","author":"Placzek","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/jpet.119.256354_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"\u201cBehavioural despair\u201d in rats and mice: strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.119.256354_bib35","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0024-3205(87)90585-6","article-title":"Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists","volume":"40","author":"Portoghese","year":"1987","journal-title":"Life Sci"},{"key":"10.1124\/jpet.119.256354_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/npp.2017.205","article-title":"Repeated administration of opra kappa (LY2456302), a novel, short-acting, selective KOP-r antagonist, in persons with and without cocaine dependence","volume":"43","author":"Reed","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.119.256354_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neuroscience.2012.06.006","article-title":"Chromatin alterations in response to forced swimming underlie increased prodynorphin transcription","volume":"220","author":"Reed","year":"2012","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.119.256354_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2013.09.021","article-title":"LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders","volume":"77","author":"Rorick-Kehn","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.119.256354_bib39","doi-asserted-by":"crossref","first-page":"pyu036","DOI":"10.1093\/ijnp\/pyu036","article-title":"Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human","volume":"18","author":"Rorick-Kehn","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.119.256354_bib40","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.256354_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pbb.2016.12.016","article-title":"Lipopolysaccharide administration induces sex-dependent behavioural and serotonergic neurochemical signatures in mice","volume":"153","author":"Sens","year":"2017","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.119.256354_bib42","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","article-title":"Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects","volume":"90","author":"Shirayama","year":"2004","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.119.256354_bib43","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1016\/j.bmcl.2004.07.081","article-title":"A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A","volume":"14","author":"Tidgewell","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.119.256354_bib44","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/00001756-199408150-00018","article-title":"Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors","volume":"5","author":"Unterwald","year":"1994","journal-title":"Neuroreport"},{"key":"10.1124\/jpet.119.256354_bib45","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00213-017-4647-0","article-title":"Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats","volume":"234","author":"Valenza","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.256354_bib46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-013-3195-5","article-title":"Role of kappa-opioid receptors in stress and anxiety-related behavior","volume":"229","author":"Van\u2019t Veer","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.256354_bib47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pnpbp.2018.06.001","article-title":"Acute inhibition of kappa opioid receptors before stress blocks depression-like behaviors in California mice","volume":"86","author":"Williams","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.119.256354_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2008.04.021","article-title":"Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey","volume":"193","author":"Yalcin","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.119.256354_bib49","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00213-003-1688-3","article-title":"Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL\/6J mice","volume":"172","author":"Zhang","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.256354_bib50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-004-2087-0","article-title":"Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors","volume":"179","author":"Zhang","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.119.256354_bib51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2967\/jnumed.112.109512","article-title":"Synthesis and evaluation of 11C-LY2795050 as a kappa-opioid receptor antagonist radiotracer for PET imaging","volume":"54","author":"Zheng","year":"2013","journal-title":"J Nucl Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524259061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524259061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.256354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T15:57:37Z","timestamp":1739980657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524259061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0022356524259061"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.256354","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Pharmacological Manipulation of the \u03ba-Opioid Receptor System on Self-grooming and Anhedonic-like Behaviors in Male Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.256354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}